Evidence map›Paper›PMID 38734794›Full record

ArticleArchives of dermatological research2024

Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study.

Jia Jian, Min Li, Pei Qian, Ji Li, Yan Tang, Fangfen Liu, Zhixiang Zhao, Jundong Huang, Wei Shi

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jia Jian *Hu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China.
Min Li *Hu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China.
Pei QianHu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China.
Ji LiHu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China.
Yan TangHu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China.
Fangfen LiuHu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China.
Zhixiang ZhaoHu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China.
Jundong HuangHu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China. 1012797233@qq.com.
Wei ShiHu Nan Key Laboratory of Aging Biology, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410000, China. shiwei@csu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alopecia AreataCost-Benefit AnalysisDrugs, GenericPiperidinesPyrimidinesPyrrolesAdultFemaleHumansMaleMiddle AgedProtein Kinase InhibitorsRetrospective StudiesTreatment OutcomeYoung AdultDrugs, GenericPiperidinesProtein Kinase InhibitorsPyrimidinesPyrrolestofacitinibAlopecia areataEffectivenessGeneric tofacitinibSafetyTreatment

Identifiers

PMID38734794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.